Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Revealed: who responds best to popular weight management medications

Contributed by: PA Media Press Centres

Tags

Numan
WeightLoss

More Like This

First GLP-1 tablet for weight loss approved in the UK

Slimming World Logo

Lose weight, keep it off – the science behind staying slim long term

Two in Three Patients Hide Weight Loss Treatment, UK Study Finds

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

PR Newswire associated0

Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors

PR Newswire associated0

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026

Over 55,000 people already on Simple Online Healthcare's waitlist for UK's first, newly approved oral GLP-1

2 in 3 patients hide weight loss treatment from friends and family, new UK study finds

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us